
The European Medicines Agency (EMA) has announced the adoption of the ICH E6(R3) Guideline for Good Clinical Practice (GCP) at...
The European Medicines Agency (EMA) has announced the adoption of the ICH E6(R3) Guideline for Good Clinical Practice (GCP) at...
Join us on 17-18 September 2025, in Madrid for the Farmaforum – Clinical Research Forum. Discover key insights into the...
Looking for must-read training material on ICH GCP E6(R3)? Check out the Step 4 presentation published by ICH GCP –...
The ICH E6 (R3) Guideline reached Step 4 of the ICH process on 06-Jan-2025. This marks a major milestone in...
In December 2024, the FDA published a draft guidance titled “Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and...
Yesterday 6th January 2025, the U.S. Food and Drug Administration (FDA) released a draft guidance titled “Considerations for the Use...